Search Results 241-250 of 8302 for Conduction

  1. A research study to look at long-term treatment with a medicine called NNC6019-0001 for people who have heart failure due to transthyretin amyloidosis - Mayo Clinic

    Current treatment with calcium channel blockers with conduction system effects (e.g., verapamil, diltiazem). The use of dihydropyridine calcium channel ...

  2. Congenital heart disease in adults - Doctors and departments - Mayo Clinic

    ... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...

  3. Cardiovascular Medicine - Doctors - Mayo Clinic

    ... Conduction system disease. Show more areas of focus for Anca Chiriac, M.D., Ph.D. Pagination Doctor search. Go to page 11 · Go to page 22 · NextNext Page. Learn ...

  4. Saline-Enhanced Radiofrequency Catheter Ablation for the Treatment of Ventricular Tachycardia - Mayo Clinic

    Subjects with VTs of septal origin require special care to minimize the risk of heart block, particularly within 2 cm of the AV node/proximal conduction ...

  5. Cardiovascular Medicine - Doctors - Mayo Clinic

    ... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...

  6. Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma - Mayo Clinic

    Active conduction system abnormalities; NOTE: prior to study entry, any electrocardiogram (ECG) abnormality at screening must be documented by the ...

  7. Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid - Mayo Clinic

    Evidence of any of the following cardiac conduction abnormalities during the screening period: A QTc Fredericia interval >450 milliseconds for males and ...

  8. A Study Evaluating Pembrolizumab and Epacadostat in Treating Participants With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma - Mayo Clinic

    For subjects with an intraventricular conduction delay (QRS interval > 120 msec), the JTc interval may be used in place of the QTc with sponsor approval.

  9. A Study to Evaluate the Effectiveness and Safety of G10 in Subjects with Transthyretin Amyloid Cardiomyopathy - Mayo Clinic

    Requires treatment with calcium channel blockers with conduction system effects (e.g., verapamil, diltiazem). The use of dihydropyridine calcium channel ...

  10. Cardiovascular Medicine - Doctors - Mayo Clinic

    ... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...